BACKGROUND: This study was designed to examine the cytotoxic effect of retinoic acid on the blastocyst stage of mouse embryos and on subsequent early postimplantation embryo development in vitro. METHODS AND RESULTS: Mouse blastocysts were exposed for 24 h to doses of 0, 0.1 mmol/l and 10 mmol/l all-trans retinoic acid and observed for their capacity to implant and develop during the early postimplantation period in vitro. When retinoic acid-pretreated blastocysts were allowed to implant in vitro, signi®cantly fewer embryos were able to reach a later stage of embryo development. Compared with the ®ndings for the control blastocysts, exposure to retinoic acid resulted in a signi®cant reduction in the average number of total cells in blastocysts and the trophectoderm/inner cell mass lineage. The effect was associated with a signi®cant increase in the frequency of cells identi®ed as being engaged in apoptosis by means of the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling and Annexin V techniques. CONCLUSIONS: This is the ®rst evidence that retinoic acid induces cell death (apoptosis) and inhibits cell proliferation in mouse blastocysts. This results in the retardation of early postimplantation blastocyst development and subsequent blastocyst death.
Introduction
Vitamin A and its physiological metabolites, retinoic acid (RA) and other retinoids have profound effects on embryo morphogenensis, cell growth and differentiation, vision, and reproduction (DeLuca, 1991; Gudas, 1992; Eskild and Hansson, 1994; Hofmann and Eichele, 1994) . In addition, RA is a valuable compound for the therapy of cystic acne and numerous other dermatological disorders (Bollag et al., 1983; Becherel et al., 1996; Duell et al., 1996) and may have potential for combination biotherapy for the treatment of malignant disease including cancers of ovary, breast, lung, liver and blood (Solary et al., 1994; Kim et al., 1996; Guzey et al., 1998; Mangiarotti et al., 1998; Srivastava et al., 1999) . While normal embryo development requires retinoids, too much or too little at the wrong stage or wrong time can adversely affect the developing embryo (Sporn et al., 1991) . Several animal studies have demonstrated a potential adverse effect of RA when administered during mid and late pregnancy in mice. Administration of RA on day 7 or day 8 of gestation causes retardation of general development, abnormal differentiation of the cranial neural plate and abnormal development of the hindbrain (Morriss-Kay et al., 1991). Administration of RA on day 9 of gestation induces dysmorphogenensis of the inner ear in mice (Frenz et al., 1996) . Abnormalities of limb and neural plate development have been induced when RA is administered between day 10 and day 16 of gestation (Kochhar, 1973; Kochhar et al., 1984; Stafford et al., 1995) . Previous studies have shown the occurrence of mRNA expression of all three RA receptors (RAR) a, b and g in mouse and bovine blastocysts (Wu et al., 1992; Mohan et al., 2001) . These ®ndings suggest that RA may be involved in the developmental process of preimplantation mammalian embryos. It has been demonstrated that in-utero exposure to excess RA during the preimplantation period (early cleavage stage) does not result in any adverse effect on preimplantation embryo development (blastocyst formation) (Huang and Lin, 2001 ). However, in-vitro exposure to excess RA during the peri-implantation (blastocyst stage) and early postimplantation period does result in early growth retardation and subsequent embryo death for postimplantation embryos . Some teratogenic effects of retinoids may be due to their ability to induce apoptosis. Cellular responses to RA in vitro range from cell death to differentiation. RA-induced cell death with characteristics of apoptosis has been observed in several murine embryonic studies (Kochhar et al., 1993; Lee et al., 1994; Clifford et al., 1996; Okazawa et al., 1996; Chiba et al., 1997; Finley et al., 1999; Lu and Dong, 1999; Shum et al., 1999; Stewart et al., 2000; Suwa et al., 2001) . However, there are no reports that demonstrate the RA-induced effects on blastocysts. Because the blastocyst is composed of the inner cell mass (ICM), blastocoele and trophectoderm (TE), the effects of RA on blastocysts include: (i) the action of RA in the ICM; (ii) the action of RA in the TE; (iii) the interaction between ICM and TE. In order to study further the relevant mechanism by which RA affects the viability of blastocysts, this study was designed to examine the cell-killing effect of RA on the blastocyst stage of mouse embryos and on subsequent early postimplantation embryo development in vitro.
Materials and methods
Collection of mouse blastocysts ICR mice (6±8 weeks old) were induced to superovulate by injecting 5 IU pregnant mare's serum gonadotrophin (PMSG; Sigma Chemical Co., St Louis, MO, USA) followed 48 h later by injecting 5 IU hCG (Serono, NV Organon Oss, The Netherlands). They were then mated overnight with a single fertile male of the same strain. Mating was con®rmed by the presence of a copulatory plug the following day. The ICR virgin albino mice, male mice and pregnant mice were maintained on breeder chow and kept under a 12 h day/12 h night regimen, with food and water available ad libitum. All animals received humane animal care as outlined in the Guidelines for Care and Use of Experimental Animals (Canadian Council on Animal Care, Ottawa, 1984) . The morning after an overnight mating period, female mice with vaginal plugs were separated and used experimentally. The day a vaginal plug was found was de®ned as day 0 of pregnancy. Embryos were obtained by¯ushing the uterine horn and Fallopian tubes on the afternoon of day 3 of gestation with CMRL-1066 culture medium (Gibco Life Technologies, Grand Island, NY, USA) containing 1 mmol/l glutamine and 1 mmol/l sodium pyruvate (Sigma). The embryos were collected in uncoated plastic 35 mm Falcon culture dishes and washed a minimum of three times. Expanded blastocysts from different females were pooled and randomly selected for the various experiments.
Embryo culture
Blastocysts were cultured for assessment of implantation in vitro and further embryonic differentiation according to a modi®cation of an established method . The embryos were cultured in 1 ml of culture medium in 4-well Multidishes (Nunc, Roskilde, Denmark) at 37°C under 5% CO 2 in air. For group culture, ®ve embryos were cultured per well. CMRL-1066 was used as the basic culture medium. It was supplemented with 1 mmol/l glutamine and 1 mmol/l sodium pyruvate plus 50 IU/ml penicillin and 50 mg/ml streptomycin (Gibco). Following the 24 h culture using different dose of retinoic acid without serum supplementation, all groups of embryos were cultured in the same condition (RA-free) for 7 days. During the ®rst 3 days the culture medium was supplemented with 20% fetal calf serum (Gibco) and thereafter with 20% heated-inactivated human placental cord serum. Embryos were inspected daily under a dissecting microscope and classi®ed according to an established method (Witschi, 1972) . Developmental parameters, such as hatching through the zona pellucida, attachment to the culture dishes, trophoblastic outgrowth and differentiation of the embryo proper into early or late egg cylinders (germ layer stage) or primitive streak to early somite stage were recorded daily throughout the 8 day culture period. Embryonic development was observed through a phase-contrast microscope (Olympus IMT-2, Tokyo, Japan). To decrease observer bias, all the data were analysed using the following criteria. Implanted blastocyst was de®ned as the attachment and outgrowth of the blastocyst to the culture dish. An early egg cylinder (EEC) embryo was de®ned as an embryo that had reached stages 9 or 10 by day 4. A late egg cylinder (LEC) embryo was de®ned as an embryo that reached stages 11, 12 or 13 by day 6 of culture. An early somite (ES) embryo was de®ned as an embryo that had reached stages 14 or 15 by day 8.
Experimental design (24 h exposure to all-trans retinoic acid at the blastocyst stage in all experiments) Experiment 1 (morphological development in vitro) Expanded blastocysts were exposed to 0 (n = 150), 0.1 (n = 145) or 10 (n = 165) mmol/l all-trans RA without serum supplementation for 24 h. This covers concentrations expected in embryos after oral administration (Kraft et al., 1989) in the treated group. They were then washed in RA-free medium and further cultured in CMRL-1066 medium in order to assess their further development as outlined above. All-trans RA (Sigma) was prepared in an aqueous solution of 0.01% dimethyl sulphoxide (DMSO) and a similar solution of DMSO alone was used as the control. Brie¯y, 0, 0.1 or 10 mmol/l of RA was added on the ®rst day of culture to the treated group. Over the following 7 days of culture, the culture medium was changed to CMRL-1066 without RA in both the treatment and control groups.
Experiment 2 (effect of RA on cell proliferation in blastocysts)
A total of 208 blastocysts was incubated in 0, 0.1 or 10 mmol/l RA for 24 h and washed in RA-free medium following the incubation. The proliferation of blastocysts was evaluated by counting separately the number of ICM and TE cells identi®ed by dual differential staining (Pampfer et al., 1990 ). This method is based on immunosurgery, considering the impermeability of the TE layer, which protects the ICM cells from exposure to the antibody and the complement reaction. The two cell lineages can be distinguished following¯uorochrome staining ( Figure 1 ). According to the protocol, the zona pellucida was removed by incubating the blastocysts in 0.4% pronase in M 2 medium supplemented with 0.1% bovine serum albumin (M 2 -BSA). The denuded blastocysts were then exposed to 1 mmol/l of trinitrobenzenesulphonic acid (TNBS) in BSA-free M 2 medium (M 2 ) containing 0.1% PVP at 4°C for 30 min (Hardy et al., 1989) and washed with M 2 . Further, the blastocysts were treated with 30 mg/ml anti-dinitrophenol-BSA complex antibody in M 2 -BSA at 37°C for 30 min. After rinsing, the blastocysts were incubated in M 2 supplemented with 10% whole guinea-pig serum as a source of complement, 20 mg/ml bisbenzimide and 10 mg/ml propidium iodide at 37°C for 30 min. The immunolysed blastocysts were gently transferred onto a slide and protected from light before observation. Under appropriate UV light excitation, the ICM cells, which take up bisbenzimide but exclude propidium iodide (PI) were stained blue, whereas the TE cells, which are labelled with both¯uorochromes, were stained orange±red. Because multinucleated cells have been shown to be infrequent in preimplantation embryos (Gardner and Davies, 1993) , the number of nuclei was considered as an accurate measure of the number of cells.
Experiment 3 (effect of RA on cell death in blastocysts) TUNEL labelling: A total of 284 blastocysts was incubated to 0, 0.1 or 10 mmol/l of RA for 24 h and washed in RA-free medium following the incubation. The blastocysts following the 24 h treatment were used in this study. After ®xation, permeabilization, blocking and extensive washing, the embryos were subjected to TUNEL labelling involving dUTP biotin nick-end labelling by using an in-situ cell death detection Adverse effects of retinoic acid on mouse blastocyst kit (Roche Molecular Biochemicals, Mannheim, Germany) according to the company's instructions. Brie¯y, each group of embryos was incubated with 20 ml of the TUNEL reaction mixture containing 2 ml of enzyme solution and 18 ml of labelling solution (containinḡ uorescein-conjugated nucleotides) for 30 min at 37°C. After incubation, embryos were washed extensively with phosphatebuffered saline (PBS) buffer plus 0.3% BSA. Converted-POD (20 ml) was added to embryos and incubated for 30 min at 37°C. After incubation, the embryos were washed extensively with PBS buffer. Finally, 20 ml of DAB-substrate solution was added to embryos and incubated for 2 min at room temperature. Photographic images ( Figure 1A±C ) were taken using a¯uorescence microscope (Zeiss, Axioskop, Germany) under bright light.
Annexin staining: A total of 183 blastocysts was incubated in 0, 0.1 or 10 mmol/l of RA for 24 h and washed in RA-free medium following the incubation. The blastocysts following the 24 h treatment were used in this study. An Annexin V±FLUOS staining kit (Roche) was used to stain these embryos according to the manufacturer's instructions. According to the protocol, the zona pellucida was removed by incubating the blastocysts in M 2 -BSA. Embryos were washed well with PBS plus 0.3% BSA. They were incubated with a mixture of 100 ml binding buffer, 1 ml¯uorescein isothiocyanate (FITC) conjugated Annexin V and 1 ml PI for 60 min. After incubation, the embryos were washed well before photographic images were taken under a¯uorescence microscope (Zeiss) with bright light and under UV light with DAPI/FITC/Ron Daman triple ®lters. This kit contains PI to determine the integrity of the plasma membrane and Annexin V to detect the translocation of phosphatidylserine (PS) from the inner face to the outer surface of the plasma membrane. In apoptotic cells, the cells translocate PS from the inner face of the plasma membrane to the cell surface while maintaining membrane integrity. Once on the cell surface, PS can easily be detected by staining with FITCconjugated Annexin V, a protein that will speci®cally bind to PS. However, in necrotic cells, the broken plasma membrane allows PI, a DNA binding dye, to enter the cell through broken membranes to bind to the cellular DNA. Thus, apoptotic, necrotic and viable cells can be distinguished. Apoptotic cells stain positive for Annexin V (green) and necrotic cells stain positive for PI (red), while viable cells with an intact plasma membrane and no translocated PS are negative for both Annexin V and PI (colourless). The illustration is shown in Figure 1D±H .
Statistical analysis c 2 -test and one-way ANOVA were used as appropriate. Differences of P < 0.05 were considered to be signi®cant.
Results
Effect of RA on blastocyst development in vitro As shown in Table I , 165 blastocysts treated with 10 mmol/l RA, 145 blastocysts treated with 0.1 mmol/l and 158 control blastocysts were used for implantation in vitro. Implantation was similar in both treatment and control groups. However, in the treatment group, the formation of a 2-layer ICM and the formation of an ectoplacental cone were signi®cantly reduced. In the treatment group, fewer embryos developed to the advanced egg cylinder stages (LEC and ES stages) when compared with the control group (logistic regression: effect of concentration, P < 0.001; effect of development, P < 0.0001; interaction, P = 0.02).
Effect of RA on cell proliferation Blastocysts that had been exposed to 0.1 or 10 mmol/l of RA developed less well and were found to contain fewer cells after 24 h than the control blastocysts. The differential staining techniques revealed that the effect of RA on cell number was more pronounced in the TE than in the ICM. A 17% cell de®ciency was observed in the TE lineage following exposure to 10 mmol/l of RA (P = 0.007; Figure 2A ).
Effect of RA on cell death
The results of the culture experiments were con®rmed in that cell death, as detected by TUNEL, increased 2±3-fold in blastocysts exposed to 10 mmol/l RA. The effect of RA on cell apoptosis was more pronounced in the ICM than in the TE ( Figure 2B ). Cell death was also detected by Annexin V staining kit. The percentage of Annexin V positive embryos in each group was analysed. There was a higher rate of Annexin V positive ICM in blastocysts treated with RA than in the control blastocysts ( Figure 2C ). However, there was a similar rate of Annexin V positive TE in blastocysts treated with RA than in the control blastocysts ( Figure 2C) . Furthermore, the mean number of necrotic cells in the blastocysts was similar between the control and treatment groups ( Figure 2D ).
Discussion
The results of this study demonstrate that cell death in the mouse blastocysts that are transiently (24 h) exposed to RA and cultured in vitro is affected by excess RA. Blastocysts exposed to 10 mmol/l RA contain three times as many dead cells as blastocysts not exposed to RA as measured by the TUNEL staining method. Cell death was also detected by the Annexin V staining method and the percentage of apoptosis was signi®cantly higher in the ICM lineage of the treated blastocysts than the control blastocysts. In contrast, the incidence of cell necrosis in RA-exposed blastocysts was similar to that of the control blastocysts. After 24 h exposure to RA, the blastocysts revealed retarded postimplantation development leading to embryonic death even though they could implant onto the cultured dishes. This suggests that excess RA can decrease the viability of mammalian blastocysts and can regulate cell death in the blastocysts.
Embryonic development is a complex process that is extremely sensitive to vitamin A as both de®ciency and excess can lead to abortion and embryonic malformation. It is reasonable to interpret these results as suggesting that an excess of RA disrupts the normal developmental programme and leads to a serious retardation as demonstrated in the present study. In previous studies, the adverse effects of RA were found to be dose-dependent at the different stages of embryo Witschi (1972) .
Adverse effects of retinoic acid on mouse blastocyst development. Mouse embryos exposed to excess RA (12 mg/ kg) on day 7 3 4 of development showed retardation of general development, abnormal differentiation of the cranial neural plate and abnormal development of the hindbrain (Morriss-Kay et al., 1991) . The morphological features of embryos from treated mice were characterized by a reduced somite number, reductions in the pharyngeal arch size and number, a rostrally displaced otocyst, delayed closure of the anterior neuropore, as well as retardation of heart development. These effects of RA were related to the expression of the Hox-2.9 and Krox-20 genes, which in turn reduced the expression of the TGF-b 1 and TGF-b 2 proteins. Maternal exposure to RA (20 mg/kg) on day 9 of gestation has been found to induce dysmorphogenesis of the inner ear in mouse embryos (Frenz et al., 1996) . Similarly, a congenital limb anomaly can be induced following exposure of pregnant Swiss±Webster mice to non-physiological levels of RA (120 mg/kg) on days 10 and 11 of gestation (Kochhar, 1973; Kochhar et al., 1984) . Additionally, elevated RA doses (30 mg/kg) adversely affected early postimplantation embryogenesis on days 3 or 4 of gestation (F.J. Huang et al., unpublished results) . However, 50 mg/kg of RA does not affect early or late preimplantation embryos adversely and even higher doses of RA (100 mg/kg) did not adversely affect the development of late preimplantation embryos (Huang and Lin, 2001) . In contrast, RA in vitro (10 mmol/l) does affect germ layer and subsequent neurula development from day 3 to day 8 of gestation . These ®ndings suggest that embryos at different stages have different tolerances for For all graphs, *P < 0.05, **P < 0.01 and ***P < 0.0001 respectively from the control value by one-way ANOVA or c 2 -test. increases in RA concentration. It has been shown that RA suppresses mesodermal gene expression in mouse embryonic stem cells (Bain et al., 1996) and induces endodermal gene expression in F9 embryonal carcinoma cells . These ®ndings suggest that the teratogenic effects of RA on early postimplantation embryos may be mediated by disruption of germ layer-speci®c gene activities.
Embryonic cells in embryo development are often poised between proliferation and apoptosis. It has been shown that RA-induced apoptosis is involved in embryonic development. For example, RA inhibited the proliferation and induced apoptosis of ectomesenchymal stem cells. These in¯uences may contribute to the formation of cleft palate and other orofacial congenital malformation (Lu et al., 1999; Suwa et al., 2001) . RA has an important role in digit separation with the increase of apoptotic cell death, as shown in limb development (Stewart et al., 2000; Kochhar et al., 1993; Lee et al., 1994; Tamagawa et al., 1995) . RA also induced down-regulation of Wnt-3a, involving induction of widespread apoptosis in the tail bud cells of mouse embryo (Shum et al., 1999) . In the present study, excess RA inhibited the proliferation (reduced cell number) and induced apoptosis in the ICM of mouse blastocysts. This may result in the postimplantation embryo retardation in vitro.
The TE is a sphere of epithelial cells surrounding the ICM and the blastocoel. Trophoblast cells arising at the blastocyst stage as the TE are required for development in the mammalian conceptus and contribute to the placenta (Cross et al., 1994) , which is critical for the survival of mammalian embryos. Trophoblast stem cells treated with RA were compromised in their ability to proliferate and exhibited properties of differentiation into giant cells (Yan et al., 2001) . This may implicate a function for RA in giant-cell formation during placentation. Furthermore, in-vitro studies performed with human trophoblastic cells demonstrated that the secretion of hCG and trophoblast differentiation are stimulated by retinoids (Tarrade et al., 2001) . Although RA inhibited the proliferation (reduced cell number) and induced apoptosis in the TE of mouse blastocyst in the present study, this did not inhibit the embryo implantation in vitro. However, giant-cell formation and differentiation were dif®cult to demonstrate in the present invitro model.
The molecular mechanisms underlying the induction of developmental apoptosis by RA are beginning to be understood. A stress protein of the HSP 100/Clp family (HSP 110) could represent a biochemical event of apoptotic cell death induced by RA, administered to embryos at day 9 post coitum (Evrard et al., 2000) . This effect resulted in craniofacial malformation similar to those of mandibulofacial dysostosis in man. Retinoic acid and bone morphogenetic protein 4 (BMP4) together induce p27 protein leading to retinoblastoma (Rb) protein activation and ultimately apoptosis in P19 embryonal carcinoma cells (Glozak and Rogers, 2001) . Apoptosis induced by RA may operate by a mechanism activated by reactive oxygen species in embryonic stem cell death (Castro-Obrego Ân and Covarrubias 1996) .
There are several reports regarding the effects of RA on different stages of postimplantation embryos, embryonal stem cell, embryonal carcinoma cells, or trophoblast stem cells. As a follow-up to the previous studies (Huang and Lin, 2001; , this study is the ®rst to show that RA induced cell death (apoptosis) in blastocysts, which can result in subsequent retardation of postimplantation developmental and/or death. However, the molecular mechanism of apoptosis by RA in blastocysts and the interaction between ICM and TE need to be determined in further studies.
